Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
An expert panel’s draft recommendation gives injectable PrEP an A grade, which will make the HIV prevention option more widely available.
Although 71% of survey respondents were aware of PrEP, just 19% had ever used HIV prevention pills.
New formulations and alternative injection sites could allow people to administer the shots at home.
Apretude for HIV prevention is as effective for trans women as it is for gay men, with no adverse effects on hormone therapy.
Generic cabotegravir, an every-other-month injectable to prevent HIV, will arrive in select countries. WHO and Health Gap have opinions.
The prevention pills—and newer methods—have averted countless HIV cases, but they still aren’t reaching everyone who could benefit.
Under provisions of the Affordable Care Act, insurers must cover costs related to PrEP.
Currently, fewer than 1 in 10 women eligible for HIV prevention medications are taking them.
Previous research has shown low rates of use of HIV prevention products, but the tide could be turning.
However, the benefit would be less evident in Georgia, the state with the highest lifetime risk of acquiring HIV.
HIV, hepatitis and LGBTQ advocates lead the charge. Plus, a study suggests that long-acting injectable PrEP isn’t cost effective.
New HIV treatment guidelines boost TAF and dolutegravir but warn about Trogarzo and advise against Cabenuva for pregnant people.
Every-other-month cabotegravir injections may work even better than daily pills for HIV prevention.
Starting today, the CDC recommends that clinicians prescribe pre-exposure prophylaxis to anyone who asks for it.
Injections of cabotegravir given once every two months may work even better than daily pills for HIV prevention.
Cabotegravir injections and daily Truvada are both highly effective, but some people may find it easier to use the long-acting regimen.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.